ICD-9-CM

Excludes:

carcinoma in situ (234.0-234.9)

199 Malignant neoplasm without specification of site Excludes: malignant carcinoid tumor of unknown primary site (209.20) malignant (poorly differentiated) neuroendocrine carcinoma, any site (209.30) malignant (poorly differentiated) neuroendocrine tumor, any site (209.30) neuroendocrine carcinoma (high grade), any site (209.30)
199.0: Disseminated Carcinomatosis unspecified site (primary) (secondary) Generalized: cancer unspecified site (primary) (secondary) malignancy unspecified site (primary) (secondary) Multiple cancer unspecified site (primary) (secondary)
199.1: Other Cancer unspecified site (primary) (secondary) Carcinoma unspecified site (primary) (secondary) Malignancy unspecified site (primary) (secondary)
199.2: Malignant neoplasm associated with transplanted organ Code first complication of transplanted organ (996.80-996.89) Use additional code for specific malignancy

199 Malignant neoplasm without specification of site

Excludes:

malignant carcinoid tumor of unknown primary site (209.20)

malignant (poorly differentiated) neuroendocrine carcinoma, any site (209.30)

malignant (poorly differentiated) neuroendocrine tumor, any site (209.30)

neuroendocrine carcinoma (high grade), any site (209.30)

Carcinomatosis unspecified site (primary) (secondary)

Generalized:

cancer unspecified site (primary) (secondary)

malignancy unspecified site (primary) (secondary)

Multiple cancer unspecified site (primary) (secondary)